The role of urokinase type plasminogen activator receptor in colorectal cancer

被引：0
|
作者：
Herszenyi, L [1 ]
Farinati, F [1 ]
Plebani, M [1 ]
Carraro, P [1 ]
De Paoli, M [1 ]
Istvan, G [1 ]
Sapi, Z [1 ]
Naccarato, R [1 ]
Tulassay, Z [1 ]
机构：
[1] Univ Miami, Budapest, Hungary
来源：
GASTROENTEROLOGY | 1999年 / 116卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G1846
引用
收藏
页码：A421 / A421
页数：1
相关论文
共 50 条
  • [21] Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer
    Bing-Tao Zhai
    Huan Tian
    Jing Sun
    Jun-Bo Zou
    Xiao-Fei Zhang
    Jiang-Xue Cheng
    Ya-Jun Shi
    Yu Fan
    Dong-Yan Guo
    Journal of Translational Medicine, 20
  • [22] Tissue urokinase-type plasminogen activator receptor levels in breast cancer
    Gong, SJ
    Rha, SY
    Chung, HC
    Yoo, NC
    Roh, JK
    Yang, WI
    Lee, KS
    Min, JS
    Kim, BS
    Chung, HC
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2000, 6 (03) : 301 - 305
  • [23] The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis
    Wang, Y
    MEDICINAL RESEARCH REVIEWS, 2001, 21 (02) : 146 - 170
  • [24] Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer
    Zhai, Bing-Tao
    Tian, Huan
    Sun, Jing
    Zou, Jun-Bo
    Zhang, Xiao-Fei
    Cheng, Jiang-Xue
    Shi, Ya-Jun
    Fan, Yu
    Guo, Dong-Yan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [25] Urokinase type plasminogen activator receptor: New prognostic factor in gastric cancer
    Herszenyi, L
    Farinati, F
    Plebani, M
    Carraro, P
    DePaoli, M
    Roveroni, G
    Naccarato, R
    Tulassay, Z
    GUT, 1997, 41 : A158 - A158
  • [26] Urokinase type plasminogen activator and inhibitor type-1 plasma levels in colorectal cancer
    Herszenyi, L
    Farinati, F
    Istvan, G
    De Paoli, M
    Roveroni, G
    Plebani, M
    Naccarato, R
    Tulassay, Z
    GASTROENTEROLOGY, 2001, 120 (05) : A599 - A600
  • [27] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 I IN BREAST-CANCER CELLS
    WAJIMA, T
    DEGEN, D
    ORIZ, V
    VONHOFFOLIN, DD
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1284 - 1284
  • [28] Role of Urokinase Plasminogen Activator Receptor in Gastric Cancer: A Potential Therapeutic Target
    Ma, Ying-Yu
    Tao, Hou-Quan
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2012, 27 (05) : 285 - 290
  • [29] ROLE OF PLASMA LEVEL OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1 (PAI 1), ITS GENE POLYMORPHISM AND INHIBITOR OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) AND UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) IN TUMOUR TISSUE IN COLORECTAL CARCINOMA PATIENTS
    Halamkova, J.
    Kiss, I.
    Pavlovsky, Z.
    Cech, Z.
    Tomasek, J.
    Tucek, S.
    Svobodnik, A.
    Hanakova, L.
    Moulis, M.
    Penka, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 149 - 149
  • [30] A C/T polymorphism in the urokinase-type plasminogen activator gene in colorectal cancer
    Przybylowska, K
    Smolarczyk, K
    Blasiak, J
    Kulig, A
    Romanowicz-Makowska, H
    Dziki, A
    Ulanska, J
    Pander, B
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2001, 20 (04) : 569 - 572
12345